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Abstract
Background: It is generally recognized that the inflammatory reaction in glia is one of the important pathological
factors in brain ischemic injury. Our previous study has revealed that opening ATP-sensitive potassium (K-ATP) channels
could attenuate glial inflammation induced by ischemic stroke. However, the detailed mechanisms are not well known.
Methods: Primary cultured astrocytes separated from C57BL/6 mice were subjected to oxygen-glucose deprivation
(OGD); cellular injuries were determined via observing the changes of cellular morphology and cell viability. MicroRNA
(miR) and messenger RNA (mRNA) level was validated by real-time PCR. The interaction between microRNA and the
target was confirmed via dual luciferase reporter gene assay. Expressions of proteins and inflammatory cytokines were
respectively assessed by western blotting and enzyme-linked immunosorbent assay.
Results: OGD resulted in astrocytic damage, which was prevented by K-ATP channel opener nicorandil. Notably, we
found that OGD significantly downregulated miR-7 and upregulated Herpud2. Our further study proved that miR-7
targeted Herpud2 3′UTR, which encoded endoplasmic reticulum (ER) stress protein-HERP2. Correspondingly, our results
showed that OGD increased the levels of ER stress proteins along with significant elevations of pro-inflammatory
cytokines, including tumor necrosis factor α (TNF-α) and interleukin 1β (IL-1β). Pretreatment with nicorandil could
remarkably upregulate miR-7, depress the ER-related protein expressions including glucose-regulated protein 78
(GRP78), C/EBP-homologous protein (CHOP), and Caspase-12, and thereby attenuate inflammatory responses and
astrocytic damages.
Conclusions: These findings demonstrate that opening K-ATP channels protects astrocytes against OGD-mediated
neuroinflammation. Potentially, miR-7-targeted ER stress acts as a key molecular brake on neuroinflammation.
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Background
Astrocytes are specialized and most numerous glial cell
types in the brain, they play crucial roles in central ner-
vous system (CNS) homeostasis [1]. Except for providing
support to neurons under ischemia-hypoxic condition,
astrocytes can also secrete a series of pro-inflammatory
and anti-inflammatory cytokines to modify the ambient
microenvironment [2, 3]. Post-ischemic inflammation me-
diated by astrocytes is a vital contributing factor in the
CNS injury [4–10]. Brain ischemia induces damage to as-
trocytes and stimulates the release of pro-inflammatory
cytokines, such as tumor necrosis factor-α (TNF-α) and
interleukin-1β (IL-1β), which are crucial for the patho-
logical processes of brain ischemic injury [11].
It has been revealed that ischemic injury could trigger
endoplasmic reticulum (ER) stress, which subsequently
inspires inflammatory response process and cellular
damage [12, 13]. In mild ER stress, the unfolded-protein
response (UPR) processes are activated, which is served
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to synthesis of new chaperons to refold the unfolded pro-
tein [13]. Consequently, this process could compensate
damage. However, the intense and prolonged ER stress
could activate apoptotic pathways, such as the upregula-
tion of the CEBP homologous protein (CHOP) and the ac-
tivation of pro-apoptotic protein-caspase-12, and thereby
result in cell death. Our previous study revealed that ATP-
sensitive potassium (K-ATP) channels were involved in
cerebral ischemia injury and post-ischemic inflammation
[14, 15], but the potential molecular mechanisms remain
not well understood.
Recently, considerable evidences support microRNAs
as an important regulatory molecule of astrocytic func-
tions in ischemic stroke [16–19] and regarded them as
potential candidates for stroke therapeutics. MicroRNAs
are small molecule non-coding RNAs; various aspects of
microRNAs as well as their targets have been reported.
By the transcription and/or translation of protein-coding
genes, microRNAs exert many biological functions such
as regulating ER stress, inflammation, and apoptosis
[20–22].
In the present study, we found that oxygen-glucose
deprivation (OGD) elevated ER stress and inflammatory
injuries in astrocytes. Our further study revealed for the
first time that OGD decreased inflammation-associated
microRNA 7 (miR-7) but increased the messenger RNA
(mRNA) levels of Herpud2, one of the miR-7’s targets.
Pretreatment with nicorandil could upregulate miR-7
and alleviate OGD-induced ER stress and inflammatory
injuries in astrocytes. These results suggest that miR-7
may be a potential target for the anti-inflammation effect
of nicorandil.
Methods
Cell cultures and treatment
Primary culture of astrocytes was prepared as previously
described [23]. Cortices were aseptically separated from 2-
day-old C57BL/6 mice pups, minced, and dissociated by
trypsinization. Then, they were plated on T75 culture
flasks in Dulbecco’s modified Eagle’s medium (DMEM)
containing 10 % fetal bovine serum (FBS) and incubated
at 37 °C in an incubator supplemented with 5 % CO2.
After 14 days, the flasks were shaken for 1 h at 37 °C to
remove the other glia. The astrocytes were then detached
by trypsinization and plated in six-well plates at a density
of 1 × 106 cells/ml. In the drug-treated group, cells were
pretreated with nicorandil (a K-ATP channel opener)
(TOCRIS, Bristol, UK) for 1 h before OGD and persisted
to reoxygenation 24 h. The control group was treated by
the vehicle. The experimental groups were divided as fol-
lows: (A) control; (B) nicorandil (10 μM); (C) OGD; and
(D) OGD plus nicorandil (10 μM). All experimental pro-
cedures were approved by IACUC (Institutional Animal
Care and Use Committee of Nanjing University of Chinese
Medicine).
Oxygen-glucose deprivation and reoxygenation model
The protocol was previously described [15]. After washing
twice, astrocytes were immersed in 1-ml deoxygenated
custom DMEM without glucose and FBS (GIBCO, CA,
USA). Then, they were placed inside an incubator
(Thermo scientific, Waltham, MA, USA) for 5 h with a
premixed gas (1 % O2, 94 % N2, 5 % CO2). After that, cells
were immersed in normal DMEM containing 10 % FBS
and transferred to a CO2 incubator (95 % air and 5 %
CO2) for 24 h. For non-OGD group, cultures were incu-
bated in DMEM containing 5.5-mM D-glucose (GIBCO,
CA, USA) and 10 % FBS and placed in 5 % CO2 in air at
37 °C for 28 h.
Cell viability analysis
The MTT assay was used to evaluate the cell viability as
previously described [11]. Primary cultured astrocytes
were seeded onto 96-well plates at a density of 5 × 104
cells per well. After OGD 5 h and reoxygenation 24 h,
the MTT (0.5 mg/ml) was dissolved in the cell medium
and incubated at 37 °C for 4 h. Then, we used dimethyl
sulfoxide (DMSO) to dissolve the MTT-formazan prod-
uct. The absorbance was obtained by a Dynatech MR5000
plate counter at a test wavelength of 570 nm.
Real-time PCR for mRNA
Total RNA was extracted with Trizol Reagent (Invitrogen,
USA) following the manufacturer’s instructions; 20 million
cells were used per milliliter of Trizol. Then, complemen-
tary DNA (cDNA) was synthesized from 1 μg total RNA
in a 20-μl total volume containing 4-μl mRNA Reversed
Transcription Kit (Takara 036A, Japan) and RNase-free
water. Reaction was performed in a Thermal Cycler as
follows: 42 °C for 15 min, 87 °C for 5 s, and 4 °C forever.
PCR amplifications were performed on the ABI 7300
Sequence Detection System (Applied Biosystem, USA);
they were performed in a total volume of 20 μl, containing
1 μl cDNA sample and 10 SYBR Green PCR Master Mix
(Roche, UK). PCR amplifications were always performed
in double wells, using the universal temperature cycles:
10 min at 95 °C, followed by 40 cycles consisting of 15 s at
95 °C and 1 min at 60 °C. The quantification was per-
formed by the comparative Ct (cycle threshold) method,
using the glyceraldehydes 3-phosphate dehydrogenase
(GAPDH) as internal control. Primers (Sangon Biotech,
Shanghai) used for real-time PCR are as listed in Table 1.
Real-time PCR for miRNA
Total RNA was isolated with Trizol Reagent (Invitrogen,
USA) following the manufacturer’s instruction. Reverse
transcription was performed using the Takara MicroRNA
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ReverseTranscription Kit (Takara 037A, Japan). Total
RNA (500 ng) was reverse-transcribed with 2 μl 5×Prime-
Script Buffer, 0.5 μl PrimeScript RT Enzyme Mix, 1 μl
Specific miRNA RT primer, RNA 1 μl, and 5.5 μl RNase-
free water. Reverse transcription reaction was performed
in a thermal cycler as follows: 42 °C for 15 min, 87 °C for
5 s, and 4 °C forever. PCR amplifications were performed
on the ABI 7300 Sequence Detection System (Applied
Biosystems, USA); they were performed in a total volume
of 20 μl, containing 1 μl cDNA sample and 10 SYBR
Green PCR Master Mix (Roche, UK). PCR amplifications
were always performed in double wells, using the universal
temperature cycles: 10 min at 95 °C, followed by 40 cycles
consisting of 15 s at 95 °C and 1 min at 60 °C. The expres-
sion of miR-7 was normalized using U6 as the internal
control. Measurements were normalized to U6 (ΔCt) and
comparisons calculated as the inverse log of the ΔΔCT to
give the relative fold change for miR-7 level. Primers
(Shanghai GenePharma Co., Ltd, Shanghai) used for real-
time PCR are listed in Table 1.
Plasmids
The 3′UTRs of Herpud2 mRNA harboring the predicted
miR-7a binding sequences were PCR amplified from
mouse genomic DNA and cloned into Bam HI and Xho I
of the pLUC-Report luciferase vector (Shenzhen Kangbio
Biological Technology Co., Ltd, Shenzhen, Guangdong) to
generate the Herpud2-3′UTR reporter construct. Muta-
genesis of predicted targets with a mutation of 7 bp from
the site of perfect complementarity was performed using a
site-directed Mutagenesis Kit (Takara). The primers are
listed in supplementary Table 1.
Dual luciferase target validation assays
HEK 293T cells were plated at a density of 2 × 104 cells/
well in 96-well plates 1 day before transfection. When cells
were grown to 50 % confluence in 96-well plates, they
were co-transfected with 0.2 μg plasmid DNA, 0.15 μg
sensor reporter gene, and 0.45 μg miR-7 mimics or
miRNA negative control (NC) (Gemma Pharmaceutical
Technology Co., Ltd, Shanghai) using Fugene (Roche)
according to the manufacturer’s instructions. After 48 h,
cells were lysed and assayed using dual luciferase reporter
assay system (Promega) according to the manufacturer’s
protocol. Results were displayed as relative luciferase ac-
tivity, while Renilla luciferase activity was normalized to
firefly luciferase activity.
Western blotting
The cytosolic and nuclear proteins in samples were ex-
tracted according to the KEYGEN protein extraction kit
(Nanjing, Jiangsu, China). Protein concentrations were
determined using the Beyotime BCA Kit (Beyotime Bio-
technology, Shanghai). The supernatants (30 μg protein)
were separated by Tris-glycine SDS-PAGE, transferred
to PVDF membranes (Millipore, USA) with the electro-
phoretic transfer system (Trans-blot Semi-dry Transfer
Cell, Bio-Rad, Hercules, CA, USA), and blocked with
5 % nonfat dry milk in Tris-HCl buffer saline (TBS, pH
7.4) containing 0.1 % Tween 20 (TBS-T) for 1 h at room
temperature. Then, the PVDF membranes were incu-
bated with primary antibody against glucose-regulated
protein 78 (GRP78) (1:1000, CST, Boston, USA), CHOP
(1:1000, CST, Boston, USA), Caspase-12 (1:800, CST,
Boston, USA), H3 (1:800, Bioworld Technology, USA),
nuclear factor κB (NF-κB) (1:800, Bioworld Technology,
USA), phosphorylated IκB kinase a/β (pIKK a/β) (1:800,
CST, Boston, MA, USA), and glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) (1:1000, CST, Boston, USA)
overnight at 4 °C. After being washed in TBS-T, the mem-
branes were incubated with corresponding secondary anti-
body for 1 h at room temperature. Finally, visualization of
the signal was performed by enhanced chemiluminescence
(Ultra-Lum, Claremont, CA, USA). Quantification of
bands was made by scanned densitometric analysis and
Image J analysis system.
Enzyme-linked immunosorbent assay
After 24 h reoxygenation, we collected the medium from
astrocytes. Release of the pro-inflammatory cytokines
(TNF-α and IL-1β) from the cellular supernatant was
performed using specific enzyme-linked immunosorbent
Table 1 The primers for PCR amplification
Gene name Forward (5′ to 3′) Reversed (5′ to 3′)
Herpud2 (mouse) GGCCCAGTGCTGAATGAAGA CAGCATGGCTCCCATTACCA
GAPDH (mouse) CATGGCCTTCCGTGTTCCTA CCTGCTTCACCACCTTCTTGAT
miR-7 RT (mouse) AGCATTCGTCTCGACACAGCAACAAAATC
MiR-7 (mouse) TGACTCTGCTGGAAGACTAGTGAT TAGAGCATTCGTCTCGACACAG
U6 RT (mouse) AACGCTTCACGAATTTGCGT
U6 (mouse) CTCGCTTCGGCAGCACA AACGCTTCACGAATTTGCGT
WT vector for Herpud2 3′UTR (mouse) cacaactcgagTAAGCTTCTCATGCATATGA aaggatccGGGCAAGATGCTACTAGCACA
Mut vector for Herpud2 3′UTR (mouse) TACTGCAGAAGGAGCTTTATTCATTTCAATTATGTGTA AGCTCCTTCTGCAGTACTGTTAGCAATGCTATGTTGTTAG
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assays (ELISAs) (R&D Systems, UK) according to manu-
facturers’ guidelines.
Statistical analysis
Data are shown as mean ± S.E.M. Unless stated otherwise,
all statistical quantitative assessments were carried out
and performed in a blinded manner: for two groups,
paired t test, for three or more groups, one-way analysis of
variance (ANOVA) followed by Student-Newman-Keuls
tests. Differences were considered significant for P < 0.05.
Results
Nicorandil attenuates OGD-induced injury in astrocytes
Normally, astrocytes are shaped by finely branched pro-
cesses and have a small round body, as shown in
Fig. 1A(a). Under OGD state, the appearance of astrocytes
changed in a time-dependent manner. After OGD for 3 h
and reoxygenation for 24 h, the appearance of some astro-
cytes displayed as large round body (Fig. 1A(b)) and the
cell viability determined by MTT assay showed significant
decrease (Fig. 1B). After OGD for 5 h and reoxygenation
for 24 h, all of the astrocytes became reactive and
displayed a stellated and hypertrophic with shorter
processes and larger round cell body (Fig. 1A(c)), com-
panied by a significant decrease of cell viability (Fig. 1B);
When the OGD duration extended to 7 h, they exhibited
disruption of cellular morphology and decrease in number
(Fig. 1A(d)) with much more remarkable decrease of cel-
lular MTT activity (Fig. 1B). However, pretreatment with
nicorandil (1~10 μM) could attenuate OGD-induced de-
crease of cellular MTT activity and improved cellular
morphology damaged by OGD-induced injury (Fig. 1D).
MiR-7 targets the 3′UTR of Herpud2
MiR-7 is proved to be involved in cancer, diabetes melli-
tus, and Parkinson’s disease via targeting inflammation-
related proteins. It was indicated by computational
miRNA target prediction algorithms TargetScan (http://
www.microrna.org) that miR-7 could potentially target
the 3′UTR domain of Herpud2 (HERP2), which was one
of the HERP family members, acting as an important ER
stress-related molecule. Thus, we determined the time-
course of Herpud2 mRNA level and miR-7 via real-time
PCR. Results demonstrated that expression of miR-7 in
Fig. 1 Nicorandil attenuates OGD-induced astrocytic injury. A The representative morphological alteration of astrocytes after different time-points
of OGD. (a) Control, (b) OGD 3 h, (c) OGD 5 h, (d) OGD 7 h. Scale bar: 100 μm. B The time-course of cell viability changes induced by OGD in
astrocytes. The changes of cell viability (C) and morphological alteration (D) of astrocytes pretreated with nicorandil. (a) Control, (b) nicorandil
(10 μM), (c) OGD, (d) OGD plus nicorandil (10 μM). Scale bar: 100 μm. Data are represented as means ± S.E.M. from four independent experiments.
***P < 0.001 vs. control group; ###P < 0.001 vs. OGD group
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astrocytes was obviously downregulated by about 40 %
since OGD for 5 h and reoxygenation for 24 h (Fig. 2a).
Conversely, Herpud2 mRNA showed significant increase
(Fig. 2b). To validate whether miR-7 really targeted the
3′UTR of Herpud2, we constructed Herpud2-3′UTR re-
porter and used dual luciferase target validation assays
to confirm the hypothesis. A construct containing the 3′
UTR of Herpud2 mRNA or the sequence with the mu-
tant seed region was co-transfected along with miR-7
mimics or mimics NC into HEK293T cells. As shown in
Fig. 2c, compared to mimics NC group, co-transfection
of Herpud2 WT 3′UTR with miR-7 mimics could sig-
nificantly reduce the relative luciferase activity. More-
over, this targeting effect was specific because there was
no significant change of the relative luciferase activity on
condition of co-transfection of Herpud2 Mut 3′UTR
with miR-7 mimics (Fig. 2c). Therefore, these results dem-
onstrated that miR-7 targeted the 3′UTR of Herpud2. To
further study whether nicorandil affected expression of
miR-7 and the target, we pretreated astrocytes with nicor-
andil and found that pretreatment with nicorandil
(10 μM) could reverse OGD-induced decrease of miR-7
(Fig. 2d) and increase of Herpud2 mRNA (Fig. 2e). These
results implied that nicorandil protected against OGD-
induced injury might be related to miR-7.
MiR-7 alters expression of Herpud2 and concerned with
the protection of nicorandil against OGD-induced injury
To further verify the effects of miR-7, we established
miR-7 mimic and inhibitor and transfected them into
primary cultured astrocytes. We noted that transfection
with miR-7 inhibitor or mimic could result in decrease
Fig. 2 Nicorandil restrains OGD-induced upregulation of Herpud2 mRNA via miR-7. Time-course of OGD induced the changes of miR-7 (a) and
Herpud2 mRNA (b) in astrocytes. c The target of miR-7 to Herpud2 3′UTR via Dual Luciferase Reporter Assays. Expression of miR-7 (d) and Herpud2
mRNA (e) pretreated by nicorandil. Data are represented as means ± S.E.M. from four independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001 vs.
control; #P < 0.05, ###P < 0.001 vs. OGD group
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or increase of miR-7. Transfection with 20- or 40-pM in-
hibitor could respectively induce downregulation of miR-7
by 33 and 45 % (Fig. 3a). While we used transfection with
40-pM miR-7 mimic, the result demonstrated that it could
lead to an increase of about 62-fold in miR-7 level (Fig. 3b).
Moreover, we also found that both transfection with miR-
7 inhibitor (40 pM) and mimic (40 pM) altered expression
of Herpud2 mRNA (Fig. 3c); this was further evidenced
when miR-7 regulated the expression of Herpud2 mRNA.
As we proved that pretreatment with nicorandil protected
against OGD-induced injury and changed expression of
miR-7, to further study whether the protection of nicoran-
dil depended on miR-7, we transfected primary astrocytes
with miR-7 inhibitor before pretreatment with nicorandil
and detected cell viability by MTT assay. Interestingly, as
shown in Fig. 3d, pretreatment with nicorandil (10 μM)
could reverse OGD-induced decrease of cell viability;
however, transfection with miR-7 inhibitor abolished this
effect. Results indicated that nicorandil protected against
OGD-induced injury depending on miR-7.
Nicorandil depresses OGD-induced ER stress
Previous studies demonstrated that ER stress was crucial
for brain ischemia injury. Our study proved miR-7 targeted
the important ER stress relevant protein-HERP2, and
nicorandil protected against OGD-induced injury de-
pending on miR-7. To further verify whether nicorandil
affected OGD-induced ER stress, we detected the ex-
pressions of three key important ER stress-related
proteins, including molecular chaperon (GRP78/Bip),
transcription factor (CHOP), and apoptosis-related pro-
tein (Caspase-12). Our results showed that GRP78,
CHOP, and Caspase-12 were significantly upregulated
in astrocytes after OGD (Fig. 4a–d). But pretreatment
with nicorandil (10 μM) could inhibit OGD-induced
upregulation of these ER stress proteins (Fig. 4a–d).
These data confirmed that nicorandil could indeed de-
press OGD-induced ER stress.
Nicorandil attenuates OGD-induced inflammatory
responses
ER stress easily stimulates inflammatory responses, both
of them were crucial for brain ischemic injury. Therefore,
we also observed the effect of nicorandil on OGD-induced
inflammatory responses. As shown in Fig. 5, results
displayed that OGD could upregulate the expression of
phosphorylated IKKα/β (Fig. 5a) and nuclear NF-κB
(Fig. 5b). Moreover, it could also increase the release of
Fig. 3 MiR-7 is indispensable for the protection of nicorandil against OGD-induced injury. Dose response of miR-7 level in primary cultured astrocytes
after transfection with miR-7 mimic (a) and/or inhibitor (b). c Herpud2 mRNA level in primary cultured astrocytes transfected with miR-7 mimic and
inhibitor. d Cell viability of astrocytes after pretreatment with nicorandil and (or) miR-7 inhibitor. Data are represented as means ± S.E.M. from four
independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001 vs. control; #P < 0.05, ###P < 0.001 vs. OGD group; $$P < 0.01 vs. OGD plus nicorandil
pretreatment group
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pro-inflammatory cytokines (TNF-α and IL-1β) to cell
supernatant (Fig. 5c, d). However, pretreatment with
nicorandil (10 μM) could reverse these effects; it could
decrease OGD-induced upregulation of phosphorylated
IKKα/β (Fig. 5a) and nuclear NF-κB (Fig. 5b) as well as
reduced the content of pro-inflammatory cytokines in-
cluding TNF-α (Fig. 5c) and IL-1β (Fig. 5d). Our research
showed that nicorandil could attenuate OGD-induced in-
flammatory responses mediated by NF-κB signaling
pathway.
Discussion
Dysfunctions of reactive astrocytes are essential for
the pathological processes of many CNS diseases, such
as stroke, Parkinson’s disease, and Alzheimer’s disease
[3, 24–26]. Accumulating studies suggest that ER stress
and inflammation in astrocytes are important mechanisms
involved in brain injury [27–29]. In the present study, our
results also proved that both ER stress and inflammation
are responsible for OGD-induced injury in astrocytes.
Opening K-ATP channels could protect against OGD-
induced inflammatory damage in astrocytes.
The endoplasmic reticulum is an important subcellular
compartment and dispensable for cell survival; particu-
larly, it plays an irreplaceable role in folding and process-
ing cellular proteins. At the early stage of ER stress,
unfolded-protein response (UPR) was initiated and dem-
onstrated by accumulation of unfolded proteins including
GRP78 and HERP [30]. It has been proved the pivotal
roles of GRP78 in dysfunction of astrocytes during is-
chemic stroke [31], but little is mentioned about HERP.
There are two types of HERP, such as HERP1 and
HERP2, which are respectively encoded by Herpud1
and Herpud2 gene. HERP2 is constitutively expressed
in cells, whereas HERP1 is highly induced by ER stress
[32]. Both of them are essential for ER stress; they
mainly participate in the process of ER-associated deg-
radation and mediate ER stress-induced inflammation.
Deficiency of HERP could attenuate ER stress-induced
inflammatory reaction in atherosclerosis [33]. Most of
the scientists focus on their functions but pay little
attention to their regulation. MicroRNAs are proved to
regulate gene expression at the post-transcriptional
level, via degradation or translational inhibition of their
target mRNAs [34]. In the present study, we found that
miR-7 targeted the 3′UTR of Herpud2 (Fig. 2c). Our
data showed that OGD could downregulate miR-7
(Fig. 2a) and upregulate mRNA level of Herpud2
(Fig. 2b); it motivated ER stress via upregulating ER
stress proteins including GRP78, CHOP, and Caspase-
12 (Fig. 4a–d). Thus, our study suggested that miR-7
might be an important upstream sign that modulate
ER-associated degradation. MiR-7 is a proven small
molecule that implicates in inflammation in various
diseases [35], such as neurodegenerative disease and
glioma [11, 36–38]. Our study revealed that miR-7 was
Fig. 4 Nicorandil depresses OGD-induced endoplasmic reticulum stress. a Represented immunoblots of GRP78, CHOP, and Caspase-12. Immunoblotting
analyses of GRP78 (b), CHOP (c), and Caspase-12 (d) in astrocytes. Data are represented as means ± S.E.M. from four independent experiments.
*P < 0.05, **P < 0.01 vs. control group; ##P < 0.01 vs. OGD group
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also involved in OGD-induced ER stress and inflamma-
tory responses in astrocytes.
ER stress is one of the most important acute-phase re-
sponses that mediate inflammatory responses. ER stress
and inflammation interconnected through various mech-
anisms including activation of NF-κB signaling pathway
[39]. The present data showed that OGD induced in-
crease of pro-inflammatory cytokines including TNF-α
and IL-1β. Inflammation induced by OGD was mediated
by activating pro-inflammatory transcription factor NF-
κB, which was the central mediator of pro-inflammatory
pathway. Activated IKK phosphorylates inhibitor of κB,
initiating inhibitor of κB and thereby leading to NF-κB ac-
tivation, activated NF-κB then migrate to the nucleus, and
facilitated transcription of pro-inflammatory cytokines
such as TNF-α and IL-1β, which were transcribed by NF-
κB [39]. In the present study, results demonstrated that
OGD promoted production of TNF-α and IL-1β, which
was mediated by phosphorylation of IKKα/β and activa-
tion of nuclear NF-κB. Opening K-ATP channel could in-
hibit OGD-induced inflammatory responses. These results
suggested that K-ATP channels were an important regula-
tor for OGD-induced inflammation.
The K-ATP channels widely express and act as an im-
portant sensor of energetic metabolism. Ischemia or OGD
leads to cellular energy loss, which contributes to the
dysfunction of K-ATP channels. In turn, dysfunction of
K-ATP channels results in the intolerance of cells to
stress. Particularly, K-ATP channels are abundant in the
endoplasmic reticulum; dysfunction of them is respon-
sible for ER stress pathway [40]. Beyond that, it is
proved that K-ATP channels are pivotal for CNS
inflammation, especially in glia. K-ATP channel knock-
down increased glial reaction and production of inflam-
matory cytokines in ischemic brain [14]. K-ATP channel-
deficient mice showed more susceptible to infection [41].
All of these suggest that K-ATP channels are pivotal for
ER stress and inflammation. In the present study, pretreat-
ment with nicorandil (a K-ATP channels’ opener) could
rescue the reduction of miR-7 induced by OGD (Fig. 2d).
Meanwhile, nicorandil could attenuate ER stress (Fig. 4)
as well as decrease pro-inflammatory cytokine (TNF-α
and IL-1β) production (Fig. 5). These results suggested
that K-ATP channel’s opener alleviated OGD-mediated ER
stress and inflammation via regulating miR-7 and thereby
protected astrocytes against OGD-induced damage.
Conclusions
Our data revealed that nicorandil protected against OGD-
induced neuroinflammation damages in astrocytes. Further
Fig. 5 Nicorandil attenuates OGD-induced inflammatory responses via NF-κB signaling pathway. Represented immunoblots of phosphorylated IKKα/β
(a) and nuclear NF-κB (b). Immunoblotting analyses of phosphorylated IKKα/β (a) and nuclear NF-κB (b). Data are represented as means ± S.E.M. from
four independent experiments. *P < 0.05, **P < 0.01 vs. control group; #P < 0.05 vs. OGD group. ELISA assays of TNF-α (c) and IL-1β (d) in the
supernatant, n = 8. *P < 0.05, **P < 0.01 vs. control group; #P < 0.05, ##P < 0.01 vs. OGD group
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studies showed for the first time that miR-7 targeted the
3′UTR of Herpud2, which might be crucial for OGD-
induced ER stress and inflammation in astrocytes.
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